ArticleEJHaem2024

Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case report.

Shiqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.